[twonK]

Lexicon to Present Phase 2 Clinical Data for IBS Drug Candidate at Digestive Disease WeekHi,can anyone tell me, assuming no major hurdles, when LX1031 might hit the market? 2013 or so?Thanks,Pete

 

[Jeffrey Roberts]

Completing Phase 2 studies is still a long way from marketing. Phase 3 studies will have to be conducted, followed by an NDA (New Drug Application) to the FDA. In all these steps could take perhaps 5 years.Jeff

 

[twonK]

<sigh>